Ricerc@Sapienza

Particle therapy is increasingly used for the treatment of solid tumours, especially when the tolerance of organs at risk for conventional radiotherapy becomes dose limiting. To take full advantage of the particle therapy potential, the beam range in tissues has to be precisely known and the secondary particles production during the treatment has to be accurately characterised, as it can lead to unwanted dose deposition far from the target volume.